APLM
Apollomics Inc.
NASDAQ · Healthcare · Biotechnology · US
$19.00
−8.83%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -17.37x
- Price / sales
- 6.52x
- Price / cash flow
- -3.08x
Enterprise value
- Enterprise value
- $52.8M
- EV / sales
- 6.21x
- EV / EBITDA
- -5.64x
- EV / EBIT
- -5.57x
- Market cap
- $55.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025